NJ A4520 | 2022-2023 | Regular Session
Note: Carry Over of previous A2671
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on September 22 2022 - 25% progression, died in committee
Action: 2022-09-22 - Introduced, Referred to Assembly Consumer Affairs Committee
Pending: Assembly Consumer Affairs Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on September 22 2022 - 25% progression, died in committee
Action: 2022-09-22 - Introduced, Referred to Assembly Consumer Affairs Committee
Pending: Assembly Consumer Affairs Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Prohibits excessive charges for drugs developed by publicly funded research.
Title
Prohibits excessive charges for drugs developed by publicly funded research.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2022-09-22 | Assembly | Introduced, Referred to Assembly Consumer Affairs Committee |
Same As/Similar To
A2671 (Carry Over) 2020-02-13 - Introduced, Referred to Assembly Health Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2022/A4520 |
Text | https://pub.njleg.gov/Bills/2022/A5000/4520_I1.HTM |